
Adrebloc100 mg/10
ZAS Corporation
Esmolol Hydrochloride is an ultra-short-acting, cardioselective beta-1 adrenergic blocking agent given by intravenous (IV) infusion.
Esmolol Hydrochloride is an ultra-short-acting, cardioselective beta-1 adrenergic blocking agent given by intravenous (IV) infusion. Its evidence-based uses include:
Esmolol Hydrochloride is intended only for short-term, continuously monitored use in a hospital or critical-care setting.
Esmolol Hydrochloride is given only as a continuous, carefully monitored intravenous infusion (with or without an initial loading dose), in a setting with continuous ECG and blood pressure monitoring. Dosing is individualized and titrated to the desired heart rate/blood pressure response.
| Indication | Typical adult dosing |
|---|---|
| Supraventricular tachyarrhythmia (e.g., rate control in atrial fibrillation/flutter) | Loading dose of 500 micrograms/kg (0.5 mg/kg) IV over 1 minute, followed by a maintenance infusion starting at 50 micrograms/kg/minute for 4 minutes. If an inadequate response is seen, the loading dose may be repeated and the maintenance infusion increased in increments (e.g., up to 100, 150, then 200 micrograms/kg/minute), with each new infusion rate preceded by a repeat loading dose. Maintenance infusions above 200 micrograms/kg/minute are not generally recommended. |
| Perioperative tachycardia and/or hypertension | An initial bolus dose (e.g., 80 mg / approximately 1 mg/kg) may be given over 30 seconds, followed by an infusion of 150 micrograms/kg/minute, titrated up to 300 micrograms/kg/minute as needed, per institutional protocol and product labeling. |
See Dosage and Administration sections below for further detail, and Use in Special Populations for renal/hepatic and elderly considerations.
Side effects of Esmolol Hydrochloride are generally dose-related and resolve quickly after the infusion is stopped or the rate is reduced, given its very short half-life.
Report any unusual or severe symptoms to the treating medical team immediately, as Esmolol Hydrochloride is used under continuous monitoring.
Esmolol Hydrochloride is contraindicated in patients with:
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.